ERIC DOBMEIER Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ERIC DOBMEIER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is a Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and a Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and a Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and a V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and a Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and a Director in STEMLINE THERAPEUTICS INC ($STML) and a President, CEO in ADURO BIOTECH, INC. ($ADRO) and a Director in Adaptive Biotechnologies Corp ($ADPT) and a Director in Versartis, Inc. ($VSAR) and a Director in Atara Biotherapeutics, Inc. ($ATRA).

Address: 21823 30TH DRIVE SE BOTHELL 98021 WA

Companies in which ERIC DOBMEIER is an Insider

Adaptive Biotechnologies Corp

Trading Symbol: ADPT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Director
Holdings: 1,504 shares
Latest Transaction: Feb 17 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Aravive, Inc.

Trading Symbol: ARAV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERIC DOBMEIER: Director
Holdings: 18,160 shares
Current Value: $241,528
Latest Transaction: Dec 22 2017
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Atara Biotherapeutics, Inc.

Trading Symbol: ATRA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Director
Holdings: 28,000 shares
Current Value: $421,400
Latest Transaction: Jun 17 2020
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CHINOOK THERAPEUTICS, INC.

Trading Symbol: ADRO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERIC DOBMEIER: President, CEO
Holdings: 97,837 shares
Current Value: $1,095,774
Latest Transaction: Jun 15 2021
$ADRO Market Capitalization: $745.72M
$ADRO Previous Close: $11.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Chief Operating Officer, Chief Business Officer, Sr. VP, Corporate Development, V. P., Corporate Affairs, Vice President,
Holdings: 121,153 shares
Current Value: $7,364,891
Latest Transaction: Dec 06 2017
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

STEMLINE THERAPEUTICS INC

Trading Symbol: STML
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERIC DOBMEIER: Director
Holdings: 27,963 shares
Current Value: $173,371
Latest Transaction: Jun 20 2017
$STML Market Capitalization: $118.68M
$STML Previous Close: $6.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of ERIC DOBMEIER

Sentiment: All, ADPT, ARAV, ATRA, ADRO, SGEN, STML

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 15 2021ADROCHINOOK THERAPEUTI ...DOBMEIER ERICPresident, CEOOption ExerciseM0.3520,0007,000423,358
Jun 15 2021ADROCHINOOK THERAPEUTI ...DOBMEIER ERICPresident, CEOBuyM0.3520,0007,00097,83777.8 K to 97.8 K (+25.69 %)
Feb 17 2021ADPTAdaptive Biotechno ...DOBMEIER ERICDirectorOption ExerciseA66.503,759249,9743,759
Feb 17 2021ADPTAdaptive Biotechno ...DOBMEIER ERICDirectorGrantA0.001,50401,5040 to 1.5 K
Feb 12 2021ADROCHINOOK THERAPEUTI ...DOBMEIER ERICPresident, CEOOption ExerciseA0.0060,743060,743
Feb 12 2021ADROCHINOOK THERAPEUTI ...DOBMEIER ERICPresident, CEOOption ExerciseA15.14178,6002,704,004178,600
Jan 06 2021ADPTAdaptive Biotechno ...DOBMEIER ERICDirectorOption ExerciseM6.3210,00063,20035,000

View all ERIC DOBMEIER insider transactions.